CN116217474A - 一种n-甲基-1,2,5,6-四氢烟酸甲酯的制备方法 - Google Patents

一种n-甲基-1,2,5,6-四氢烟酸甲酯的制备方法 Download PDF

Info

Publication number
CN116217474A
CN116217474A CN202310221215.5A CN202310221215A CN116217474A CN 116217474 A CN116217474 A CN 116217474A CN 202310221215 A CN202310221215 A CN 202310221215A CN 116217474 A CN116217474 A CN 116217474A
Authority
CN
China
Prior art keywords
methyl
preparing
arecoline
nicotinate
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310221215.5A
Other languages
English (en)
Inventor
徐海斌
钱海书
应燕庆
泮文俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xianju Liangshan Biotechnology Co ltd
Original Assignee
Xianju Liangshan Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xianju Liangshan Biotechnology Co ltd filed Critical Xianju Liangshan Biotechnology Co ltd
Priority to CN202310221215.5A priority Critical patent/CN116217474A/zh
Publication of CN116217474A publication Critical patent/CN116217474A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/803Processes of preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

本发明公开了一种N‑甲基‑1,2,5,6‑四氢烟酸甲酯的制备方法,包括以下步骤:进行烟酸甲酯的制备,进行溴化烟酸甲酯铵盐的制备,进行槟榔碱的制备。本发明对槟榔碱的制备工艺做了大量优化,使用较为廉价的3‑氰基吡啶为起始原料,直接氯化氢醇解得到烟酸甲酯,操作简便,烟酸甲酯收率明显提高,废水量大大减少,成本显著降低使用溴甲烷代替碘甲烷进行甲基化得到溴化烟酸甲酯铵盐,然后用硼氢化钠、乙酸、乙醇体系进行还原,蒸馏后和氢溴酸水溶液1:1成盐,工艺安全稳定,操作简便,所得产物槟榔碱收率大大提高,质量稳定。放大20倍无明显放大效应,适合工业化生产。

Description

一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法
技术领域
本发明涉及有机合成领域,特别涉及一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法。
背景技术
槟榔碱是中药槟榔中的活性成分之一,药理研究表明其具有驱虫、促进胃肠蠕动等作用,在兽医临床上,槟榔碱主要用于治疗动物的绦虫病。长期以来,槟榔碱主要从槟榔中提取获得,然而其天然产物含量只有0.1%~0.6%,加上传统法提取率低,从而大大限制了其在临床上的应用。槟榔碱对多种寄生虫有抑制或杀灭作用。在临床上主要用于驱除绦虫,对犬绦虫的驱除效果尤为显著,但目前临床上还没有该药的原料及制剂。因而对槟榔碱及制剂的制备、药物质量控制、药代动力学研究,有非常重要的意义。
槟榔碱的化学合成主要有三种途径:(1)以3,3′-亚氨基二丙腈为原料,经过N-甲基化,腈解,缩合环化、催化氢化还原制得[(2)烟酸经过酯化、N-甲基化,再在中性或弱碱性条件下,以苯做溶剂,用NaBH4或KBH4还原鎓盐制得(3)烟酸经酯化、N-甲基化后在乙醇中用硼氢化钠-乙酸体系进行还原制得以上合成工艺都存在操作繁琐,合成条件不宜控制,收率低、产物复杂,不能批量化生产的问题。
发明内容
本发明的目的在于提供一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,包括以下步骤:
步骤一:进行烟酸甲酯的制备;
步骤二:进行溴化烟酸甲酯铵盐的制备;
步骤三:进行槟榔碱的制备。
优选的,在步骤一中,将3-氰基吡啶溶于二氯乙烷中,加入甲醇,控制在0-10度,通入干燥氯化氢,室温搅拌至3-氰基吡啶反应完全。
优选的,在步骤一中,等3-氰基吡啶反应完全后,加入水,继续搅拌,控制在20度以下用20%氢氧化钠调pH至8,分出二氯乙烷层,减压蒸馏得烟酸甲酯白色固体。
优选的,在步骤二中,将烟酸甲酯溶于无水丙酮中,降温至-5度加入溴甲烷,转入高压釜中,70-80度密闭反应,降至0度,抽滤反应液,滤饼用无水丙酮洗涤后,无水乙醇重结晶,减压干燥后得到淡黄色固体。
优选的,在步骤三中,将溴化烟酸甲酯胺盐溶于无水乙醇,冰浴下加入乙酸,控温在-10~-5℃,分批加入NaBH4,加毕去冰浴,自然升至室温后再反应3h,反应毕于冰浴下滴加水,室温反应过夜。
优选的,室温反应过夜后,减压回收乙醇,加入水至固体全溶,冰浴冷却下用10%NaOH溶液调至pH 9~10,用CH2Cl2提取,减压回收溶剂,减压蒸馏得无色油状物1。
优选的,将榔碱用乙醇稀释混匀,置电动搅拌机上搅拌,滴加氢溴酸水溶液至pH3,持续搅拌,蒸馏浓缩,浓缩物洗涤、抽滤,干燥得白色粉末—氢溴酸槟榔碱。
优选的,氢溴酸和槟榔碱摩尔反应比例为1∶1,为使槟榔碱充分反应完全,在操作中,待反应溶液pH值至3时停止加入氢溴酸,操作中将反应容器置冷水浴中,缓慢加入氢溴酸。
本发明的技术效果和优点:对槟榔碱的制备工艺做了大量优化,使用较为廉价的3-氰基吡啶为起始原料,直接氯化氢醇解得到烟酸甲酯,操作简便,烟酸甲酯收率明显提高,废水量大大减少,成本显著降低使用溴甲烷代替碘甲烷进行甲基化得到溴化烟酸甲酯铵盐,然后用硼氢化钠、乙酸、乙醇体系进行还原,蒸馏后和氢溴酸水溶液1:1成盐,工艺安全稳定,操作简便,所得产物槟榔碱收率大大提高,质量稳定。放大20倍无明显放大效应,适合工业化生产,采用3-氰基吡啶直接醇解得烟酸甲酯,收率高,成本低,污染小。目前没有相关文献报道,比用原工艺3-氰基吡啶水解得烟酸,然后再用大量硫酸催化甲醇酯化,收率提高20%,成本降低30%,而且避免大量硫酸和甲醇的使用,用溴甲烷代替碘甲烷进行N-甲基化反应,避免了昂贵原料碘甲烷的使用,使槟榔碱制造成本大大降低,未见相关文献报道,用氢溴酸水溶液直接控制pH到3能成盐,避免了氢溴酸乙醇溶液的使用。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。本发明提供了一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,对槟榔碱的制备工艺做了大量优化,使用较为廉价的3-氰基吡啶为起始原料,直接氯化氢醇解得到烟酸甲酯,操作简便,烟酸甲酯收率明显提高,废水量大大减少,成本显著降低使用溴甲烷代替碘甲烷进行甲基化得到溴化烟酸甲酯铵盐,然后用硼氢化钠、乙酸、乙醇体系进行还原,蒸馏后和氢溴酸水溶液1:1成盐,工艺安全稳定,操作简便,所得产物槟榔碱收率大大提高,质量稳定。放大20倍无明显放大效应,适合工业化生产。
Figure BDA0004116731140000041
1、烟酸甲酯的制备
Figure BDA0004116731140000042
将104g3-氰基吡啶溶于400ML二氯乙烷中,加入甲醇40g,控制在0-10度,通入干燥氯化氢100g,室温搅拌至3-氰基吡啶反应完全。加入20克水,继续搅拌1小时,控制在20度以下用20%氢氧化钠调pH至8,分出二氯乙烷层,减压蒸馏得烟酸甲酯白色固体120g收率87.6%,产品鉴别mp140~142℃
2、溴化烟酸甲酯铵盐的制备
Figure BDA0004116731140000051
将烟酸甲酯82.2g,0.6mol溶于无水丙酮(180ml)中,降温至-5度加入溴甲烷68.3g,转入500ML高压釜中,70-80度密闭反应24小时,降至0度,抽滤反应液,滤饼用无水丙酮洗涤后,无水乙醇重结晶,减压干燥后得到淡黄色固体130g,(收率91.5%,mp126~127℃)
3、槟榔碱的制备
Figure BDA0004116731140000052
将溴化烟酸甲酯胺盐(116g,0.05mol)溶于无水乙醇(560ml),冰浴下加入乙酸(300ml),控温在-10~-5℃分批加入NaBH4(38g,0.1mol),加毕去冰浴,自然升至室温后再反应3h,反应毕于冰浴下滴加水(300ml),室温反应过夜。减压回收乙醇,加入少量水至固体全溶,冰浴冷却下用10%NaOH溶液调至pH 9~10,CH2Cl2提取(600ml×3),减压回收溶剂,减压蒸馏得无色油状物1(48g,62%)
氢溴酸槟榔碱的制备
Figure BDA0004116731140000061
将以上自制槟榔碱48g用乙醇100ml稀释混匀,置电动搅拌机上搅拌,滴加氢溴酸水溶液至pH3,持续搅拌,蒸馏浓缩,浓缩物洗涤、抽滤,干燥得白色粉末—氢溴酸槟榔碱48g(收率65%,mp172-175℃),氢溴酸和槟榔碱反应生成氢溴酸槟榔碱的过程中,氢溴酸的加入量是关键影响因素。氢溴酸和槟榔碱摩尔反应比例为1∶1,为使槟榔碱充分反应完全,在实际操作中,可待反应溶液pH值至3时停止加入氢溴酸。由于此反应为剧烈放热反应,所以操作中应将反应容器置冷水浴中,缓慢加入氢溴酸。在室温下,1g氢溴槟榔碱可溶于10mL无水乙醇2mL沸乙醇,微溶于氯仿、乙醚,根据氢溴酸槟榔碱氢溴酸在乙醇中的溶解度随温度变化较大的特性,可以用无水乙醇洗涤重结晶达到纯化目的。
本研究在单倍量合成氢溴酸槟榔碱时的总收率平均为47.8%,经过放大20倍量制备的氢溴酸槟榔碱的总合成收率可达50%以上,批量制备后的总收率没有降低,说明此制备工艺稳定可靠,可用于工业生产。
最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。

Claims (8)

1.一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,包括以下步骤:
步骤一:进行烟酸甲酯的制备;
步骤二:进行溴化烟酸甲酯铵盐的制备;
步骤三:进行槟榔碱的制备。
2.根据权利要求1所述的一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,在步骤一中,将3-氰基吡啶溶于二氯乙烷中,加入甲醇,控制在0-10度,通入干燥氯化氢,室温搅拌至3-氰基吡啶反应完全。
3.根据权利要求2所述的一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,在步骤一中,等3-氰基吡啶反应完全后,加入水,继续搅拌,控制在20度以下用20%氢氧化钠调pH至8,分出二氯乙烷层,减压蒸馏得烟酸甲酯白色固体。
4.根据权利要求1所述的一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,在步骤二中,将烟酸甲酯溶于无水丙酮中,降温至-5度加入溴甲烷,转入高压釜中,70-80度密闭反应,降至0度,抽滤反应液,滤饼用无水丙酮洗涤后,无水乙醇重结晶,减压干燥后得到淡黄色固体。
5.根据权利要求1所述的一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,在步骤三中,将溴化烟酸甲酯胺盐溶于无水乙醇,冰浴下加入乙酸,控温在-10~-5℃,分批加入NaBH4,加毕去冰浴,自然升至室温后再反应3h,反应毕于冰浴下滴加水,室温反应过夜。
6.根据权利要求5所述的一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,室温反应过夜后,减压回收乙醇,加入水至固体全溶,冰浴冷却下用10%NaOH溶液调至pH9~10,用CH2Cl2提取,减压回收溶剂,减压蒸馏得无色油状物1。
7.根据权利要求6所述的一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,将榔碱用乙醇稀释混匀,置电动搅拌机上搅拌,滴加氢溴酸水溶液至pH3,持续搅拌,蒸馏浓缩,浓缩物洗涤、抽滤,干燥得白色粉末—氢溴酸槟榔碱。
8.根据权利要求7所述的一种N-甲基-1,2,5,6-四氢烟酸甲酯的制备方法,其特征在于,氢溴酸和槟榔碱摩尔反应比例为1∶1,为使槟榔碱充分反应完全,在操作中,待反应溶液pH值至3时停止加入氢溴酸,操作中将反应容器置冷水浴中,缓慢加入氢溴酸。
CN202310221215.5A 2023-03-09 2023-03-09 一种n-甲基-1,2,5,6-四氢烟酸甲酯的制备方法 Pending CN116217474A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310221215.5A CN116217474A (zh) 2023-03-09 2023-03-09 一种n-甲基-1,2,5,6-四氢烟酸甲酯的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310221215.5A CN116217474A (zh) 2023-03-09 2023-03-09 一种n-甲基-1,2,5,6-四氢烟酸甲酯的制备方法

Publications (1)

Publication Number Publication Date
CN116217474A true CN116217474A (zh) 2023-06-06

Family

ID=86576656

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310221215.5A Pending CN116217474A (zh) 2023-03-09 2023-03-09 一种n-甲基-1,2,5,6-四氢烟酸甲酯的制备方法

Country Status (1)

Country Link
CN (1) CN116217474A (zh)

Similar Documents

Publication Publication Date Title
CN109369545B (zh) 2-甲基-5-甲酸吡嗪的合成工艺
CN103664923B (zh) 硝呋太尔的制备方法
CN109553550B (zh) 一种合成二氢燕麦生物碱的方法
CN116217474A (zh) 一种n-甲基-1,2,5,6-四氢烟酸甲酯的制备方法
CN114292235B (zh) 一种地拉考昔的制备和提纯方法
CN115557928A (zh) 一种2-氯噻吩-5-甲酸的合成方法
AU2018389809A1 (en) A process for the preparation of crisaborole
CN111747926B (zh) 一种羟哌吡酮游离碱的合成工艺改进方法
CN111320571B (zh) 一种制备4-二甲氨基吡啶的方法
CN105481797B (zh) 一种盐酸吗啉脒胍的合成方法
CN110683992B (zh) 一种一锅法合成硝酸益康唑的方法
CN102115450A (zh) 4-氨基-3-苯基丁酸的制备方法
CN112694436B (zh) 一种槟榔碱的合成方法
CN112552299B (zh) 一种治疗ii型糖尿病利格列汀的制备方法
CN114369073B (zh) 一种制备高纯度氢氯噻嗪的方法
CN114044783B (zh) 一种伊多塞班及其中间体的制备方法
CN113264872B (zh) 一种富马酸卢帕他定中间体5-甲基-3-羟甲基吡啶的制备方法
CN113754527B (zh) 一种醚菌酯中间体的合成方法
CN114736116B (zh) 一种高纯度棕榈酸酐的制备方法
CN110452139B (zh) 一种2-甲基-3-溴-6-甲砜基苯腈的制备方法
CN110862311B (zh) 一种1-羟基环丙烷羧酸以及羧酸酯的合成方法
CN118047678A (zh) 一种7-溴庚酸甲酯的合成方法
CN116514647A (zh) 一种芬布芬的合成方法
CN114890940A (zh) 一种6-甲氧基-2-吡啶甲酸的合成方法
CN114685378A (zh) 一种4,6-二羟基嘧啶的制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination